Clinical trial · Observational
Expression of Aberrant CD Markers in Acute Leukemia:Retrospective Study in South Egypt Cancer Institute
NCT03743909CI-TRIAL-00035824unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
* To determine incidence of Expression of aberrant CD markers in acute leukemia in South Egypt . * Correlation between this expression and outcome of the patient.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Leukemia | Acute Leukemia | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- patients with aberrant CD markers
- description
- by flowcytometry from hospital information system
- label
- patients without aberrant CD markers
- description
- by flowcytometry from hospital information system
Primary outcomes (1)
- measure
- Expression of aberrant CD markers in acute leukemia by flowcytometry : Retrospective study in South Egypt Cancer Institute
- timeFrame
- 2008-2018
- description
- * To determine incidence of Expression of aberrant CD markers in acute leukemia in South Egypt . * Correlation between this expression and outcome of the patient.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * All cases of acute leukemia in South Egypt Cancer Institute. Exclusion Criteria: * Cases outside South Egypt Cancer Institute.
References
Publications (0)
Data not yet available
No reference posted for this study.